ENTITY

Mirxes (2629 HK)

32
Analysis
Health Care • Singapore
Mirxes is a Singapore-headquartered micro ribonucleic acid (miRNA) technology company that develops diagnostic solutions for the early detection of diseases, including cancer, cardiovascular, metabolic, and infectious diseases. Its key products include GASTROClear, a blood-based test for gastric cancer screening, and LUNGClear for lung cancer screening, along with Fortitude COVID-19 RT-qPCR test kits. The company was founded in 2014.
more
Exchange Announcement • 01 Oct 2026 19:47

(1) Quarterly Update On Business Operations And Resumption Progress; (2) Resignation Of Joint Company Secretaries, Change Of Authorised Representative And Process Agent, And Appointment Of Company Secretary; And (3) Continued Suspension Of Trading

Exchange Announcement • 04 Sep 2026 21:00

(1) Additional Resumption Guidance; And (2) Continued Suspension Of Trading

Exchange Announcement • 01 Sep 2026 08:03

List Of Directors And Their Roles And Functions

Exchange Announcement • 01 Sep 2026 08:00

(1) Resignation Of Independent Non-Executive Director; (2) Appointment Of Independent Non-Executive Director; (3) Changes In Composition Of Board Committees; (4) Non-Compliance With The Listing Rules; (5) Inside Information - Further Delay In Publication Of The 2025 Annual Results And Dispatch Of The 2025 Annual Report; (6) Inside Information - Delay In Publication Of The 2026 Interim Results And Dispatch Of The 2026 Interim Report And (7) Continued Suspension Of Trading

Exchange Announcement • 01 Jul 2026 19:31

(1) Quarterly Update On Resumption Progress; (2) Delay In Holding Of Annual General Meeting; And (3) Continued Suspension Of Trading

x